Literature DB >> 8446683

Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin.

A Blokland1, J Jolles.   

Abstract

ICV injections of streptozotocin (STREP) lower the glucose utilization of the brain and affect the cholinergic system. The present study was designed to evaluate whether STREP-treated rats have an impaired spatial discrimination performance in the Morris spatial navigation task. Performance in this task is sensitive to treatment with cholinergic antagonists. In contrast to young rats, middle-aged STREP-treated rats tended to have an impaired spatial discrimination performance in the Morris task at the end of training. In middle-aged STREP-treated rats, but not in control rats, spatial discrimination performance was associated with hippocampal choline acetyltransferase (ChAT) activity. The correlation between spatial discrimination performance in the Morris task and the decrease in hippocampal ChAT activity resembles the relation between cognitive and biochemical changes observed in Alzheimer's disease. Our findings suggest that STREP treatment of middle-aged rats may provide a relevant model for dementia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446683     DOI: 10.1016/0091-3057(93)90497-h

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  22 in total

Review 1.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

2.  Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Authors:  A Knezovic; A Loncar; J Homolak; U Smailovic; J Osmanovic Barilar; L Ganoci; N Bozina; P Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2017-05-03       Impact factor: 3.575

3.  Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats.

Authors:  L P Reagan; N Gorovits; E K Hoskin; S E Alves; E B Katz; C A Grillo; G G Piroli; B S McEwen; M J Charron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats.

Authors:  María F Zappa Villar; Juliette López Hanotte; Joaquín Pardo; Gustavo R Morel; Guillermo Mazzolini; Mariana G García; Paula C Reggiani
Journal:  Mol Neurobiol       Date:  2019-08-10       Impact factor: 5.590

5.  Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study.

Authors:  Melita Salkovic-Petrisic; Jelena Osmanovic-Barilar; Martina K Brückner; Siegfried Hoyer; Thomas Arendt; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2011-04-30       Impact factor: 3.575

6.  Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.

Authors:  Ana Knezovic; Jelena Osmanovic-Barilar; Marija Curlin; Patrick R Hof; Goran Simic; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2015-03-26       Impact factor: 3.575

7.  Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model.

Authors:  H Kübra Elcioğlu; Ersin Aslan; Sarfraz Ahmad; Saadet Alan; Emine Salva; Ö Haluk Elcioglu; Levent Kabasakal
Journal:  Mol Cell Biochem       Date:  2016-07-22       Impact factor: 3.396

Review 8.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

9.  Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences.

Authors:  M Badruzzaman Khan; Muzamil Ahmad; Saif Ahmad; Tauheed Ishrat; Kumar Vaibhav; Gulrana Khuwaja; Fakhrul Islam
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

10.  Protective effects of evodiamine in experimental paradigm of Alzheimer's disease.

Authors:  Dongmei Wang; Chenying Wang; Ling Liu; Sanqiang Li
Journal:  Cogn Neurodyn       Date:  2018-01-25       Impact factor: 5.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.